Urovant Sciences Ltd
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $138,736,000.
Profit Margin
| 2017 | 0 | -26.97M | |
|---|---|---|---|
| 2018 | 0 | -37.07M | |
| 2019 | 0 | -111.34M | |
| 2020 | 0 | -146.74M |
UROV Income Statement (2017 – 2020)
| 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|
Revenue | ||||
Revenue | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | 0 |
Operating exp. | ||||
Research and development | 92.43M | 92.19M | 32.35M | 26.04M |
Selling and marketing | 0 | 0 | 0 | 0 |
Total operating expenses | 138.73M | 110.78M | 36.99M | 27.06M |
Operating income | -142.82M | -110.78M | -36.99M | -27.06M |
Other income (expenses), net | -3.85M | -516K | -37.46K | 93.45K |
Income before tax | -146.68M | -111.29M | -37.03M | -26.97M |
Income tax expense | 65K | 47K | 37.22K | 0 |
Net income | -146.74M | -111.34M | -37.07M | -26.97M |
Earnings per share | ||||
Basic EPS | -4.89 | -3.71 | -1.23 | -0.9 |
Diluted EPS | -4.89 | -3.71 | -1.23 | -0.9 |
| Data source | Data source |